Tamibarotene, an agonist to the retinoic acid receptor alpha (RARα), was piloted in a study of MDS and AML via the identification of functional dependency on RARα through transcriptomic analysis [176]. The gene discussed is RARA; the disease is myelodysplastic syndrome.